Alpha 2.0
Login Register
» Authors » Masaaki Watanabe

Masaaki Watanabe

Explore the profile of Masaaki Watanabe including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 81
Citations 1035
Followers 0
Related Specialties
Gastroenterology
General Surgery
General Medicine
Top 10 Co-Authors
Akitaka Shibuya
Tsuyoshi Shimamura
Ryoichi Goto
Takahide Nakazawa
Akinobu Taketomi
Hisashi Hidaka
Norio Kawamura
Tsutomu Minamino
Yusuke Okuwaki
Wasaburo Koizumi
Published In
Hepatol Res
Transplantation
J Gastroenterol
Intern Med
Surg Case Rep
Affiliations
Soon will be listed here.
Recent Articles
1.
Anti-Inflammatory Effects of -Generated Donor Antigen-Specific Immunomodulatory Cells on Pancreatic Islet Transplantation
Forgioni A, Watanabe M, Goto R, Harada T, Ota T, Shimamura T, et al.
Cell Transplant . 2025 Feb; 34:9636897251317887. PMID: 39981681
Pancreatic islet transplantation (PITx) is a promising treatment option for patients with type 1 diabetes mellitus. Previously, we demonstrated that therapy with alloantigen-specific immunomodulatory cells (IMCs) generated in the presence...
2.
Intestinal obstruction caused by disseminated mycobacterium avium complex disease following solid organ transplantation: a case report
Mita A, Nakakubo S, Nishimura Y, Shima H, Watanabe M, Shimamura T, et al.
BMC Infect Dis . 2025 Jan; 25(1):120. PMID: 39863833
Background: Mycobacterium avium complex (MAC) is a common pathogen causing non-tuberculous mycobacterial infections, primarily affecting the lungs. Disseminated MAC disease occurs mainly in immunocompromised individuals, such as those with acquired...
3.
A case of simultaneous pancreatoduodenectomy and living donor liver transplantation for biliary cancer complicated with congenital biliary dilatation
Shimamura T, Watanabe M, Koshizuka Y, Goto R, Kawamura N, Orimo T, et al.
Surg Case Rep . 2024 Dec; 10(1):274. PMID: 39630322
Background: In patients with pancreaticobiliary maljunction complicated by congenital biliary dilatation, the pancreatic enzyme flows back into the bile, leading to bile duct carcinogenesis. Although the biliary tract resection and...
4.
Early graft-infiltrating lymphocytes are not associated with graft rejection in a mouse model of skin transplantation
Kanazawa R, Goto R, Harada T, Ota T, Kobayashi N, Shibuya K, et al.
Scand J Immunol . 2024 Jul; 100(4):e13397. PMID: 39080853
Graft-infiltrating lymphocytes (GILs) play an important role in promoting rejection after organ transplantation. We recently reported that GILs that accumulated up to 3 days post-transplantation did not promote rejection, whereas...
5.
RECAM-J 2023-Validation and development of the Japanese version of RECAM for the diagnosis of drug-induced liver injury
Tanaka A, Tsuji K, Komiyama Y, Tsuruya K, Kakisaka K, Tsutsui A, et al.
Hepatol Res . 2024 Apr; 54(6):503-512. PMID: 38642343
Aim: The diagnosis of drug-induced liver injury (DILI) is challenging. We modified the revised electronic version of the Roussel Uclaf Causality Assessment Method (RUCAM) for the diagnosis of DILI (RECAM),...
6.
TCF1highPD-1+Ly108+CD8+ T Cells Are Associated with Graft Preservation in Sensitized Mice Treated with Non-Fc Receptor-Binding CD3 Antibodies
Ota T, Goto R, Harada T, Forgioni A, Kanazawa R, Ganchiku Y, et al.
Immunohorizons . 2024 Apr; 8(4):295-306. PMID: 38587418
The non-Fc-binding anti-CD3 Ab [anti-CD3F(ab')2] can induce graft acceptance depending on the therapeutic window in a rodent heart transplant model. The delayed protocol allows for early graft infiltration of lymphocytes,...
7.
Long-term risk of a fatty liver in liver donors
Goto R, Kawamura N, Watanabe M, Ganchiku Y, Nagatsu A, Okada K, et al.
Ann Gastroenterol Surg . 2023 Jul; 7(4):645-653. PMID: 37416731
Aim: Approximately 30 years have passed since the first experience of living donor liver transplantation. The time to evaluate the long-term safety of living donors has been fulfilled. Meanwhile, nonalcoholic...
8.
Post-transplant donor-specific anti-HLA antibodies with a higher mean fluorescence intensity are associated with graft fibrosis in pediatric living donor liver transplantation
Goto R, Fukasaku Y, Ganchiku Y, Kawamura N, Watanabe M, Ota T, et al.
Front Pediatr . 2023 May; 11:1172516. PMID: 37181419
The roles of post-transplant anti-HLA donor specific antibody (DSA) in pediatric liver transplantation (LT), including therapeutic strategies, remain controversial. This study aimed to identify the risks of post-transplant DSA for...
9.
Significant association between HLA-B*35:01 and onset of drug-induced liver injury caused by Kampo medicines in Japanese patients
Nakamura R, Arakawa N, Tanaka Y, Uchiyama N, Sekine A, Mashimo Y, et al.
Hepatol Res . 2022 Dec; 53(5):440-449. PMID: 36583370
Aim: Drug-induced liver injury (DILI) is a severe and life-threatening immune-mediated adverse effect, occurring rarely among treated patients. We examined genomic biomarkers in the Japanese population that predict the onset...
10.
[Successful treatment of a fulminant-type Wilson's disease with deceased donor liver transplantation after recovery from critical illness]
Wakui Y, Goto R, Watanabe M, Kawamura N, Ogawa K, Mitsuhashi T, et al.
Nihon Shokakibyo Gakkai Zasshi . 2022 Dec; 119(12):1096-1102. PMID: 36504102
A 15-year-old female patient was diagnosed with a fulminant-type Wilson's disease. She had severe illness with a Model for End-Stage Liver Disease score of 25 and new Wilson Index score...